Artículos
[Anthropometric measures of central abdominal fat and discriminant capacity for metabolic syndrome in a Spanish population].
Autores: Bellido D, López de la Torre M,Carreira J, de Luis D, Bellido V, Soto A, Luengo LM, Hernández A, Vidal J, Becerra A, Ballesteros M.
CLINICAL EFFECTS OF A W3 ENHANCED POWDERED NUTRITIONAL FORMULA IN POSTSURGICAL AMBULATORY HEAD AND NECK CANCER PATIENTS.
Autores: de Luis DA, Izaola O, Cuellar L, Terroba MC, Ventosa M, Martin T, Aller R.
Relation of -55CT polymorphism of UCP3 gene with weight loss and metabolic changes after a high monounsaturated fat diet in obese non diabetic patients.
Autores: De Luis DA, Aller R, Izaola O, De La Fuente B, Conde R, Eiros Bouza JM.
Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets.
Autores: Paoli A, Rubini A, Volek JS, Grimaldi KA.
Insulin analogues: modifications in the structure, molecular and metabolic consequences
Autores: de Luis DA, Romero E.
Potential of incretin-based therapies for non-alcoholic fatty liver disease.
Autores: Samson SL, Bajaj M.
Improved glycaemia correlates with liver fat reduction in obese, type 2 diabetes, patients given glucagon-like peptide-1 (GLP-1) receptor agonists.
Autores: Cuthbertson DJ, Irwin A, Gardner CJ, Daousi C, Purewal T, Furlong N, Goenka N, Thomas EL, Adams VL, Pushpakom SP, Pirmohamed M, Kemp GJ.
Insulin Degludec Once-Daily in Type 2 Diabetes: Simple or Step-Wise Titration (BEGIN: Once Simple Use).
Autores: Philis-Tsimikas A, Brod M, Niemeyer M, Ocampo Francisco AM, Rothman J.
Experience over 12 years with home enteral nutrition in a healthcare area of Spain.
Autores: De Luis DA, Izaola O, Cuellar LA, Terroba MC, Cabezas G, De La Fuente B.
A randomized clinical trial with two doses of an enteral diabetes-specific suplements in elderly patients with diabetes mellitus type 2.
Autores: de Luis DA, Izaola O, de la Fuente B, Terroba MC, Cuellar L, Cabezas G.